lantern破解版 下载

lantern破解版 下载

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

lantern破解版 下载

Learn More
Folded page of a newspaper

lantern破解版 下载

lantern破解版 下载

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

lantern破解版 下载

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

lantern破解版 下载

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

lantern破解版 下载

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

lantern破解版 下载

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

lantern破解版 下载

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

极光VRN  永久不收费的加速器苹果版  原子浏览器下载  猎豹加速器每天免费1小时  奈云加速器  老王论坛最新网址